PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

acyclovir vs bictegravir/emtricitabine/tenofovir

Side-by-side comparison of acyclovir and bictegravir/emtricitabine/tenofovir Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Some examples of drugs that are eliminated by active tubular secretion include, but are not limited to, acyclovir, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs [see Warnings and Precautions (5.4) ] .

Recommendation: Your healthcare provider may need to check your kidney health more often while you use this combination.

Drug Class
acyclovir Antiviral (Nucleoside Analog)
bictegravir/emtricitabine/tenofovir Integrase Inhibitor / NRTI Combination
Type
acyclovir Prescription
bictegravir/emtricitabine/tenofovir Prescription
Summary
acyclovir

Acyclovir is an antiviral medicine. It is used to treat infections caused by certain viruses.

bictegravir/emtricitabine/tenofovir

Biktarvy is a complete HIV-1 treatment for adults and children who weigh at least 31 pounds. It combines three medicines into one tablet to help control the virus.

What It Treats
acyclovir

Acyclovir is used to treat shingles, which is caused by herpes zoster. It also treats genital herpes, both the first time you have it and when it comes back. Acyclovir can also treat chickenpox.

bictegravir/emtricitabine/tenofovir

Biktarvy treats Human Immunodeficiency Virus type 1 (HIV-1) in adults and children weighing at least 31 pounds. It can be used if you have never taken HIV medicine before. It can also replace your current HIV medicine if your virus is under control and you have no resistance to Biktarvy's components.

How It Works
acyclovir

Acyclovir stops the virus from growing and spreading. It does this by interfering with the virus's ability to make copies of itself. This helps your body fight off the infection.

bictegravir/emtricitabine/tenofovir

Biktarvy contains three drugs that each block HIV in different ways. Bictegravir stops HIV from inserting its DNA into your cells. Emtricitabine and tenofovir alafenamide interfere with an enzyme HIV needs to make copies of itself.

Common Side Effects
acyclovir
  • Malaise (feeling unwell)
  • Nausea
  • Diarrhea
bictegravir/emtricitabine/tenofovir
  • Diarrhea
  • Nausea
  • Headache
FAERS Reports
acyclovir
  • Tiredness 7,612
  • Diarrhea 7,064
  • Using the medicine for something it's not approved for 5,797
  • Lung infection 5,474
  • Feeling sick to your stomach 5,330
bictegravir/emtricitabine/tenofovir

No adverse event reports.

Serious Warnings
acyclovir

Acyclovir can cause nervous system problems, especially in older adults or people with kidney problems. Tell your doctor if you have kidney problems before taking this medicine.

bictegravir/emtricitabine/tenofovir

If you have both HIV and hepatitis B, stopping Biktarvy can cause your hepatitis B to suddenly get worse. Your doctor will need to monitor your liver closely for several months after you stop taking Biktarvy. You may need to take medicine for hepatitis B.

Pregnancy
acyclovir

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if acyclovir will harm an unborn baby. Talk to your doctor about the risks and benefits of taking acyclovir while breastfeeding.

bictegravir/emtricitabine/tenofovir

There is a pregnancy registry to track outcomes in women who take Biktarvy during pregnancy. Talk to your doctor about the risks and benefits of taking Biktarvy if you are pregnant or planning to become pregnant. There is not enough data to assess the risk of major birth defects.

Also Compare — Nearby Drugs

How to Read This acyclovir vs bictegravir/emtricitabine/tenofovir Comparison

acyclovir is classified in the Antiviral (Nucleoside Analog) drug class, while bictegravir/emtricitabine/tenofovir sits within the Integrase Inhibitor / NRTI Combination class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acyclovir has 31,277 submissions while bictegravir/emtricitabine/tenofovir has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to these medications leave the body through the same kidney filters, which could lead to a buildup of the drugs in your system.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acyclovir and bictegravir/emtricitabine/tenofovir — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.